ABO blood group and Rhesus factor as potential markers in papillary thyroid cancer: a retrospective comparative analysis (2015-2023).

Langenbecks Arch Surg · 2025 · PMC12662903 · PMID 41313453

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

did not reach statistical significancep = 0.101not close (p > 0.1)

Although the AB blood group showed a slightly higher odds ratio (OR) for malignancy compared to other blood groups, this difference did not reach statistical significance (OR = 1.363, 95% CI: 0.941–1.974, p = 0.101) (Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.